16217385

Source:http://linkedlifedata.com/resource/pubmed/id/16217385

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005695, umls-concept:C0031740, umls-concept:C0034693, umls-concept:C0034721, umls-concept:C0055366, umls-concept:C0162713, umls-concept:C0475370, umls-concept:C1120108, umls-concept:C1710493
pubmed:issue	5
pubmed:dateCreated	2005-10-11
pubmed:abstractText	PAD-S31 (13,17-bis (1-carboxypropion) carbamoylethyl-3-ethenyl-8-ethoxyiminoethylidene-7-hydroxy-2,7,12,18-tetramethyl-porphyrin sodium) (Photochemical Co., Ltd., Okayama, Japan), 1 of the latest second-generation photosensitizers, has hydrophilic characteristics and excitation wavelengths of around 670 nm. Using an orthotopic rat bladder tumor model we investigated the biodistribution of PAD-S31 and assessed the antitumor effects of photodynamic therapy (PDT) with PAD-S31.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0376374
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/13,17-bis(1-carboxypropionyl)carbamo..., http://linkedlifedata.com/resource/pubmed/chemical/Photosensitizing Agents, http://linkedlifedata.com/resource/pubmed/chemical/Porphyrins
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0022-5347
pubmed:author	pubmed-author:AraiTsunenoriT, pubmed-author:AsanumaHiroshiH, pubmed-author:KawauchiSatokoS, pubmed-author:KikuchiMakotoM, pubmed-author:MorimotoYujiY, pubmed-author:MuraiMasaruM, pubmed-author:SatohHiroyukiH, pubmed-author:SeguchiKenjiK
pubmed:issnType	Print
pubmed:volume	174
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2016-21
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:16217385-Animals, pubmed-meshheading:16217385-Biopsy, Needle, pubmed-meshheading:16217385-Disease Models, Animal, pubmed-meshheading:16217385-Female, pubmed-meshheading:16217385-Immunohistochemistry, pubmed-meshheading:16217385-Infusions, Intravenous, pubmed-meshheading:16217385-Male, pubmed-meshheading:16217385-Neoplasms, Experimental, pubmed-meshheading:16217385-Photochemotherapy, pubmed-meshheading:16217385-Photosensitizing Agents, pubmed-meshheading:16217385-Porphyrins, pubmed-meshheading:16217385-Radiation Dosage, pubmed-meshheading:16217385-Rats, pubmed-meshheading:16217385-Rats, Inbred F344, pubmed-meshheading:16217385-Risk Factors, pubmed-meshheading:16217385-Sensitivity and Specificity, pubmed-meshheading:16217385-Treatment Outcome, pubmed-meshheading:16217385-Urinary Bladder, pubmed-meshheading:16217385-Urinary Bladder Neoplasms
pubmed:year	2005
pubmed:articleTitle	Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model.
pubmed:affiliation	Department of Urology, School of Medicine, Faculty of Science and Technology, Keio University, Tokyo, Japan.
pubmed:publicationType	Journal Article